Background-Treatment of Helicobacter pylonz infection prevents duodenal ulcer relapse. It has not been established if treatment of the infection heals duodenal ulcer. Aim-To test the hypothesis that treatment of the infection was associated with healing of duodenal ulcer. Methods-A randomised, double blind placebo controlled trial was performed to study the efficacy of an antibiotic only regimen consisting of 300 mg metronidazole, 500 mg amoxycillin, and 250 mg clarithromycin, each given four times daily for two weeks, in the healing of duodenal ulcer as assessed by endoscopy. Symptoms were controlled with acetaminophen and antacids. Results-Of 100 consecutive patients with endoscopically established duodenal ulcer, 97 with positive rapid urease test on antral biopsy specimens were admitted into the study and 81 completed the trial. Of these, 40 were randomised to receive antibiotics and 41 to receive placebo. Treatment with antibiotics resulted in 92.5% (95% confidence interval (95% CI) 84-3-100) healing at four weeks and 100% at eight and 12 weeks; the corresponding healing rates for placebo treatment were respectively, 36.6%/ 61%, and 63.4% (95% CIs 21-8-51-3, 46*0-75-9, and 48-7-78-2 respectively). The differences between the two treatment groups were significant at p<0001 at each time point and by life table analysis. Clearance of H pylon as assessed by urease test on antral biopsy specimens at four weeks and eradication of the organism as determined by '3C-urea breath test at eight weeks were achieved in 85% and 62.5% of patients respectively. Duodenal ulcer healed at four weeks in 87-2% and 86-2% (95% CIs 76-7-97-7 and 73.7-98-8) of patients in whom H pylon clearance or eradication, was achieved, versus 42.9% and 51.9% (95% CIs 27-9-57-8 and 38-3-65-5; p<0001 and <0-003 respectively) in whom these processes failed. Stepwise discriminant analysis on 32 clinical, personal, and endoscopic characteristics as well as H pylon clearance and eradication identified H pylon clearance as the most discrinminative variable for the healing of duodenal ulcer at four weeks, followed by ulcer depth and eradication of the organism.
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Conclusions-Treatment with an antibiotic only regimen was effective for the healing of duodenal ulcer, and clearance as well as eradication of H pylori contributed significantly to the healing. The results constituted the strongest evidence to date that H pyloni infection was aetiologically related to duodenal ulceration, and support the concept of treating duodenal ulcer associated with Hpylorn as an infection and relieving its symptoms with acid reducing agents such as antacids.
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The finding that treatment of Helicobacterpylori infection of the stomach prevents the relapse of duodenal ulcer'-3 forms the first clue that the organism has an aetiological role in this condition. The recognition that placebos heal about one third of duodenal ulcers4 and that they do so in the presence of Hpylori infection5 seems, however, to be against such a role. Furthermore, because the therapeutic regimens used today for the treatment of the infection and for ulcer healing invariably contain, in addition to antibiotics, agents such as colloidal bismuth subcitrate, proton pump inhibitors, or sucralfate, which have established ulcer healing efficacy as well as a suppressive action on H pylori infection, 6-8 it remains unknown if treatment of the infection itself heals duodenal ulcer. Such information has important implications in the aetiology and treatment of this condition. We report the first randomised, double blind placebo controlled study on the efficacy of an antibiotic regimen directed against Hpylori infection, consisting of metronidazole, amoxycillin, and clarithromycin -but not including any known ulcer healing agent -in the short term healing of duodenal ulcer.
Methods

PATIENTS
Patients aged between 18 Drop outs: 8 8 Intolerable dyspeptic symptoms 5 6 Persistent diarrhoea because six weeks after treatment, the negative rate as determined by the '3C-urea breath test was 62/5%; this corresponded to the eradication rate of the infection described in the literature, which was arrived at after an interval of four weeks or more between the completion of treatment and the test.6 Both of these results were significantly higher than those after placebo treatment (table 2), indicating that the antibiotic regimen used was effective for the treatment of H pylori infection. These results also suggested that clearance or eradication of Hpylori contributed to the healing of duodenal ulcer. This was further supported by the finding that duodenal ulcer healed in 87-2% and 86-2% of patients in whom H pylori clearance or eradication was achieved, versus 42-9 and 51P9% in whom these processes failed (table 3) . The stepwise discriminant analysis confirmed that H pylori clearance and eradication were both discriminative for duodenal ulcer healing, together with ulcer depth (table  4) . Interestingly, the analysis also showed that clearance of the organism contributed more to ulcer healing than eradication ( 
